NZ713247A - Inhibitors of hcv ns5a - Google Patents
Inhibitors of hcv ns5aInfo
- Publication number
- NZ713247A NZ713247A NZ713247A NZ71324709A NZ713247A NZ 713247 A NZ713247 A NZ 713247A NZ 713247 A NZ713247 A NZ 713247A NZ 71324709 A NZ71324709 A NZ 71324709A NZ 713247 A NZ713247 A NZ 713247A
- Authority
- NZ
- New Zealand
- Prior art keywords
- inhibitors
- hcv ns5a
- ns5a
- hcv
- disclosed
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed are bicyclic heteroaryl compounds
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11972308P | 2008-12-03 | 2008-12-03 | |
| US17359009P | 2009-04-28 | 2009-04-28 | |
| US21488109P | 2009-04-28 | 2009-04-28 | |
| US18295809P | 2009-06-01 | 2009-06-01 | |
| US18295209P | 2009-06-01 | 2009-06-01 | |
| NZ62223309 | 2009-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ713247A true NZ713247A (en) | 2017-08-25 |
Family
ID=59742261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ713247A NZ713247A (en) | 2008-12-03 | 2009-12-02 | Inhibitors of hcv ns5a |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ713247A (en) |
-
2009
- 2009-12-02 NZ NZ713247A patent/NZ713247A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203929A1 (en) | Inhibitors of hcv ns5a hcv ns5a | |
| ZA201104911B (en) | Inhibitors of hcv ns5a | |
| CY2017005I1 (en) | QUINOXALINE MACROCYCLIC COMPOUNDS AS INHIBITORS OF HCV NS3 PROTEINS | |
| EP2398474A4 (en) | Inhibitors of hcv ns5a | |
| CY2017033I2 (en) | HCV SERINE PROTEASE INHIBITORS DERIVED FROM MACROCYCLIC PROLINE | |
| EP2575866A4 (en) | Inhibitors of hcv ns5a | |
| EP2575475A4 (en) | Inhibitors of hcv ns5a | |
| SMT201600291B (en) | INHIBITORS OF HCV PROTEASIS | |
| EP2410841A4 (en) | Substituted bicyclic hcv inhibitors | |
| EP2125870A4 (en) | Inhibitors of hepatitis c ns3 protease | |
| CR20120417A (en) | VIRUS FLAVIVIRIDAE INHIBITORS | |
| HK1170739A1 (en) | Heterocyclic compounds as inhibitors of hepatitis c virus (hcv) (hcv) | |
| EP2618665A4 (en) | Hcv ns3 protease inhibitors | |
| EP2364159A4 (en) | Deuterated macrocyclic inhibitors of viral ns3 protease | |
| HK1200847A1 (en) | Inhibitors of hcv ns5a hcv ns5a | |
| IL225908A0 (en) | Novel specific hcv ns3 protease inhibitors | |
| NZ713247A (en) | Inhibitors of hcv ns5a | |
| TH0901005440A (en) | Inhibitors of HCV NS5A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 02 DEC 2019 BY SPRUSON + FERGUSON Effective date: 20180102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 DEC 2020 BY CPA GLOBAL Effective date: 20191017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 DEC 2021 BY CPA GLOBAL Effective date: 20201015 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 DEC 2022 BY CPA GLOBAL Effective date: 20211022 |
|
| LAPS | Patent lapsed |